Quarterly Transactions Made in Lyell Immunopharma, Inc. (LYEL)
This table provides information about the institutional ownership of Lyell Immunopharma, Inc. (LYEL). The information is specifically focused on institutions that hold shares of Lyell Immunopharma, Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 4,149,189 | 2,552,187 | 6,701,376 | 797,596 | 1,206,265 | 2,003,861 | 4,697,515 | |
| Q4 2021 | 4,326,492 | 3,805,462 | 8,131,954 | 632,357 | 3,665,522 | 4,297,879 | 3,834,075 | |
| Q1 2022 | 20,406,017 | 702,549 | 21,108,566 | 1,146,077 | 2,123,969 | 3,270,046 | 17,838,520 | |
| Q2 2022 | 7,890,882 | 505,482 | 8,396,364 | 1,312,439 | 896,083 | 2,208,522 | 6,187,842 | |
| Q3 2022 | 10,881,028 | 1,301,704 | 12,182,732 | 3,573,420 | 0 | 3,573,420 | 8,609,312 | |
| Q4 2022 | 7,890,333 | 16,160,557 | 24,050,890 | 2,864,447 | 0 | 2,864,447 | 21,186,443 | |
| Q1 2023 | 2,597,138 | 3,328,929 | 5,926,067 | 3,485,122 | 0 | 3,485,122 | 2,440,945 | |
| Q2 2023 | 10,936,443 | 1,219,819 | 12,156,262 | 6,342,704 | 0 | 6,342,704 | 5,813,558 | |
| Q3 2023 | 3,657,156 | 597,567 | 4,254,723 | 4,201,280 | 0 | 4,201,280 | 53,443 | |
| Q4 2023 | 7,518,024 | 10,527,079 | 18,045,103 | 7,783,648 | 0 | 7,783,648 | 10,261,455 | |
| Q1 2024 | 3,769,052 | 5,276,263 | 9,045,315 | 6,136,845 | 0 | 6,136,845 | 2,908,470 | |
| Q2 2024 | 8,901,892 | 1,429,469 | 10,331,361 | 7,199,832 | 0 | 7,199,832 | 3,131,529 | |
| Q3 2024 | 3,083,483 | 1,418,292 | 4,501,775 | 7,925,934 | 0 | 7,925,934 | -3,424,159 | |